Methods for assessing endometrial receptivity of a patient after controlled ovarian hyperstimulation
AssigneesInserm (Institut National De La Sante Et De La Recherche Medicale), Universite De Montpellier 1
InventorsSamir Hamamah, Delphine Haouzi
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods and kits for assessing the endometrial receptivity of a patient after controlled ovarian hyperstimulation. More particularly, the invention relates to a method for assessing the endometrial receptivity of a patient after controlled ovarian hyperstimulation, comprising a step consisting of measuring the expression level of at least one gene selected from fifteen genes in an endometrial biopsy sample obtained from said patient wherein said genes are FGFBP1, MUC20, TM-PRSS3, PRUNE2, HES2, MGST1, ERRFI1, EDN1, SLC17A7, MET, CPT1B, DCDC2, LRRC39, IL18RAP, and FOXP1.
Claims4
A method for assessing the endometrial receptivity of a patient after controlled ovarian hyperstimulation, comprising a step of
- measuring an expression level of at least one gene selected from fifteen genes in an endometrial biopsy sample obtained from said patient wherein said fifteen genes are FGFBP1, MUC20, TMPRSS3, PRUNE2, HES2, MGST1, ERRFI1, EDN1, SLC17A7, MET, CPT1B, DCDC2, LRRC39, IL18RAP, and FOXP1.
Dependencies are inferred from the claim text.